121 related articles for article (PubMed ID: 11450187)
21. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of acute and chronic psychoses in childhood and adolescence].
Eggers Ch
MMW Fortschr Med; 2005 Dec; 147(48):41, 43-5. PubMed ID: 16389861
[TBL] [Abstract][Full Text] [Related]
23. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.
Gogtay N; Sporn A; Clasen LS; Nugent TF; Greenstein D; Nicolson R; Giedd JN; Lenane M; Gochman P; Evans A; Rapoport JL
Arch Gen Psychiatry; 2004 Jan; 61(1):17-22. PubMed ID: 14706940
[TBL] [Abstract][Full Text] [Related]
24. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
[TBL] [Abstract][Full Text] [Related]
25. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
Novak Sarotar B; Pesek MB; Agius M; Kocmur M
Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
[TBL] [Abstract][Full Text] [Related]
26. [How far is psychopathology still meaningful for the treatment of schizophrenia?].
Huber G
Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S86-91. PubMed ID: 11533856
[TBL] [Abstract][Full Text] [Related]
27. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
[TBL] [Abstract][Full Text] [Related]
28. Perspectives on treatment needs in schizophrenia.
Meise U; Fleischhacker WW
Br J Psychiatry Suppl; 1996 May; (29):9-16. PubMed ID: 8733818
[No Abstract] [Full Text] [Related]
29. [Insight in schizophrenia: assessment of 31 patients with different scales].
Travers D; Levoyer D; Millet B
Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
[TBL] [Abstract][Full Text] [Related]
30. Strategies for dosing and switching antipsychotics for optimal clinical management.
Buckley PF; Correll CU
J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
[TBL] [Abstract][Full Text] [Related]
31. Toward a better identification and treatment of schizophrenia prodrome.
Bota RG; Sagduyu K; Filin EE; Bota DA; Munro S
Bull Menninger Clin; 2008; 72(3):210-27. PubMed ID: 18990056
[TBL] [Abstract][Full Text] [Related]
32. Interictal psychoses in comparison with schizophrenia--a prospective study.
Tadokoro Y; Oshima T; Kanemoto K
Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
[TBL] [Abstract][Full Text] [Related]
33. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
34. [Prodromes of schizophrenia recurrence].
Bottai T; Cotton I; Drigeard A; Vaglio V
Encephale; 2009 Jan; 35 Suppl 1():S33-40. PubMed ID: 19268166
[TBL] [Abstract][Full Text] [Related]
35. Overview of partial compliance.
Marder SR
J Clin Psychiatry; 2003; 64 Suppl 16():3-9. PubMed ID: 14680412
[TBL] [Abstract][Full Text] [Related]
36. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
Zink M; Knopf U; Henn FA; Thome J
Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
[TBL] [Abstract][Full Text] [Related]
37. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
39. Early prodromal symptoms and diagnoses before first psychotic episode in 219 inpatients with schizophrenia.
Shioiri T; Shinada K; Kuwabara H; Someya T
Psychiatry Clin Neurosci; 2007 Aug; 61(4):348-54. PubMed ID: 17610658
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostics and therapy of depressive symptoms in schizophrenic patients].
Bottlender R; Hampel H; Sievers M; Möller HJ
MMW Fortschr Med; 2005 May; 147 Spec No 2():59-62. PubMed ID: 15968875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
